Iranian Red Crescent Medical Journal

Published by: Kowsar

Seroprevalence and Risk Factors of Hepatitis E in Eastern Iran

Zohreh Azarkar 1 , Azadeh Ebrahimzadeh 1 , * , Gholamreza Sharifzadeh 1 , Masood Ziaee 1 and Mohammad Fereidouni 2
Authors Information
1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Asthma, Allergy and Immunology Research Center, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Iranian Red Crescent Medical Journal: December 2017, 20 (S1); e41644
  • Published Online: April 8, 2017
  • Article Type: Research Article
  • Received: August 20, 2016
  • Revised: February 6, 2017
  • Accepted: February 27, 2017
  • DOI: 10.5812/ircmj.41644

To Cite: Azarkar Z, Ebrahimzadeh A, Sharifzadeh G, Ziaee M, Fereidouni M. Seroprevalence and Risk Factors of Hepatitis E in Eastern Iran, Iran Red Crescent Med J. 2017 ; 20(S1):e41644. doi: 10.5812/ircmj.41644.

Copyright © 2017, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Farshadpour F, Taherkhani R, Makvandi M. Prevalence of Hepatitis E Virus among Adults in South-West of Iran. Hepat Res Treat. 2015;2015:759589. doi: 10.1155/2015/759589. [PubMed: 26199756].
  • 2. Alvarado-Esquivel C, Sanchez-Anguiano LF, Hernandez-Tinoco J. Seroepidemiology of hepatitis e virus infection in general population in rural durango, Mexico. Hepat Mon. 2014;14(6). ee16876. doi: 10.5812/hepatmon.16876. [PubMed: 24976837].
  • 3. Abebe M, Ali I, Ayele S, Overbo J, Aseffa A, Mihret A. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia. PLoS One. 2017;12(6). e0180078. doi: 10.1371/journal.pone.0180078. [PubMed: 28650982]. [PubMed Central: PMC5484499].
  • 4. Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S, et al. Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol. 2013;5(2):172-6. [PubMed: 23825737].
  • 5. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarria JM. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol. 2015;87(11):1934-9. doi: 10.1002/jmv.24251. [PubMed: 25959136].
  • 6. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol. 2016;22(22):5143-53. doi: 10.3748/wjg.v22.i22.5143. [PubMed: 27298557].
  • 7. Eick A, Ticehurst J, Tobler S, Nevin R, Lindler L, Hu Z, et al. Hepatitis E seroprevalence and seroconversion among US military service members deployed to Afghanistan. J Infect Dis. 2010;202(9):1302-8. doi: 10.1086/656598. [PubMed: 20863230].
  • 8. Azarkar Z, Miri MR, Arjmand S. Investigating the seroprevalence of hepatitis e among blood donors referring to blood donation centers in Birjand county in Iran. Modern Care J. 2016;13(1):27-31. doi: 10.17795/modernc.9456.
  • 9. Mooij SH, Hogema BM, Tulen AD, van Pelt W, Franz E, Zaaijer HL, et al. Risk factors for hepatitis E virus seropositivity in Dutch blood donors. BMC Infect Dis. 2018;18(1):173. doi: 10.1186/s12879-018-3078-9. [PubMed: 29653521]. [PubMed Central: PMC5899381].
  • 10. Sepanlou S, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S. A Population-based Seroepidemiological Study on Hepatitis E Virus in Iran. Middle East J Dig Dis. 2010;2(2):97-103. [PubMed: 25197520].
  • 11. Verhoef L, Koopmans M, Duizer E, Bakker J, Reimerink J, Van Pelt W. Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006-2007. Epidemiol Infect. 2012;140(10):1838-47. doi: 10.1017/S0950268811002913. [PubMed: 22269886].
  • 12. Cossaboom CM, Heffron CL, Cao D, Yugo DM, Houk-Miles AE, Lindsay DS, et al. Risk factors and sources of foodborne hepatitis E virus infection in the United States. J Med Virol. 2016;88(9):1641-5. doi: 10.1002/jmv.24497. [PubMed: 26889628].
  • 13. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol. 2015;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005. [PubMed: 25150374].
  • 14. Bai MJ, Zhou N, Dong W, Li GX, Cong W, Zhu XQ. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China. Int J Infect Dis. 2018;71:42-7. doi: 10.1016/j.ijid.2018.04.003. [PubMed: 29656134].
  • 15. Raoofi R, Nazer MR, Pournia Y. Seroepidemiology of hepatitis E virus in Western Iran. Braz J Infect Dis. 2012;16(3):302-3. doi: 10.1590/S1413-86702012000300017. [PubMed: 22729203].
  • 16. Cui W, Sun Y, Xu A, Gao R, Gong L, Zhang L. Hepatitis E seroprevalence and related risk factors among seafood processing workers: a cross-sectional survey in Shandong Province, China. Int J Infect Dis. 2016;49(62):6-56. doi: 10.1016/j.ijid.2016.05.028. [PubMed: 27265612].
  • 17. Mesquita JR, Myrmel M, Stene-Johansen K, Overbo J, Nascimento MS. A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol. BMC Infect Dis. 2016;16:17. doi: 10.1186/s12879-016-1341-5. [PubMed: 26774897].
  • 18. Echevarria JM. Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population. Scientifica (Cairo). 2014;2014:481016. doi: 10.1155/2014/481016. [PubMed: 24672733].
  • 19. Faber MS, Wenzel JJ, Jilg W, Thamm M, Hohle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis. 2012;18(10):1654-7. doi: 10.3201/eid1810.111756. [PubMed: 23018055].
  • 20. Park HK, Jeong SH, Kim JW, Woo BH, Lee DH, Kim HY, et al. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis. 2012;12:142. doi: 10.1186/1471-2334-12-142. [PubMed: 22726615].
  • 21. Tadesse E, Metwally L, Alaa E. High prevalence of anti-hepatitis E virus among Egyptian blood donors. J Gen Mol Virol. 2013;5(1):9-13.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments